André Efira

1.3k total citations
35 papers, 599 citations indexed

About

André Efira is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, André Efira has authored 35 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Genetics and 8 papers in Rheumatology. Recurrent topics in André Efira's work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Eosinophilic Disorders and Syndromes (5 papers). André Efira is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Eosinophilic Disorders and Syndromes (5 papers). André Efira collaborates with scholars based in Belgium, France and Netherlands. André Efira's co-authors include Florence Roufosse, Bernard Kennès, Elie Cogan, Liliane Schandené, Catherine Sibille, Michel Goldman, Karen Willard‐Gallo, Michel Goldman, Phu-Quoc Lê and Laurence Rozen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

André Efira

33 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Efira Belgium 12 264 229 210 194 143 35 599
A Segal United States 10 290 1.1× 134 0.6× 79 0.4× 65 0.3× 100 0.7× 26 606
Susana Holgado Spain 14 228 0.9× 140 0.6× 102 0.5× 71 0.4× 39 0.3× 49 649
Ali H. Al‐Jam'a Saudi Arabia 12 63 0.2× 112 0.5× 100 0.5× 126 0.6× 95 0.7× 25 393
Masao Ogura Japan 16 95 0.4× 41 0.2× 161 0.8× 146 0.8× 113 0.8× 77 696
Mathieu Jablonski France 12 150 0.6× 72 0.3× 258 1.2× 104 0.5× 726 5.1× 16 990
M Massazza Italy 5 288 1.1× 108 0.5× 45 0.2× 141 0.7× 47 0.3× 6 893
Shuji Takei Japan 11 261 1.0× 156 0.7× 614 2.9× 54 0.3× 332 2.3× 19 922
Dominique Desvaux France 22 66 0.3× 201 0.9× 47 0.2× 75 0.4× 204 1.4× 43 1.0k
Rodolfo Puccini Italy 10 246 0.9× 104 0.5× 30 0.1× 61 0.3× 63 0.4× 19 584
C.F. Allaart Netherlands 14 142 0.5× 110 0.5× 968 4.6× 297 1.5× 55 0.4× 47 1.2k

Countries citing papers authored by André Efira

Since Specialization
Citations

This map shows the geographic impact of André Efira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Efira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Efira more than expected).

Fields of papers citing papers by André Efira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Efira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Efira. The network helps show where André Efira may publish in the future.

Co-authorship network of co-authors of André Efira

This figure shows the co-authorship network connecting the top 25 collaborators of André Efira. A scholar is included among the top collaborators of André Efira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Efira. André Efira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gulbis, Béatrice, Fleur Samantha Benghiat, Bénédicte Brichard, et al.. (2021). Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry. Blood. 138(Supplement 1). 4171–4171. 1 indexed citations
2.
Minon, Jean‐Marc, Xueying Ren, O. Kaye, et al.. (2020). Sickle cell disease and COVID‐19: Atypical presentations and favorable outcomes. SHILAP Revista de lepidopterología. 1(1). 338–341. 11 indexed citations
3.
Janssens, Ann, Yves Béguin, Catherine Lambert, et al.. (2019). PF694 TREATMENT‐FREE REMISSION AFTER TPO RECEPTOR AGONISTS IN ADULT ITP PATIENTS IN BELGIUM. HemaSphere. 3(S1). 301–301. 1 indexed citations
4.
Dedeken, Laurence, et al.. (2019). Successful transition from paediatric to adult care in sickle cell disease. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 40(6). 495–501. 1 indexed citations
5.
Nagant, Carole, Cyril Barbezange, Laurence Dedeken, et al.. (2019). Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease. PLoS ONE. 14(10). e0223991–e0223991. 11 indexed citations
6.
Drowart, Annie, et al.. (2018). Syndrome de Sweet induit par le pegfilgrastim au cours d’un syndrome myélodysplasique AREB2 : à propos d’un cas clinique. La Revue de Médecine Interne. 40(4). 258–261. 4 indexed citations
7.
Knoops, Laurent, Timothy Devos, Yves Béguin, et al.. (2016). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry. 50(7-8). 452–454. 17 indexed citations
8.
Lê, Phu-Quoc, Béatrice Gulbis, Laurence Dedeken, et al.. (2015). Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric Blood & Cancer. 62(11). 1956–1961. 122 indexed citations
9.
Kenz, Hanane El, et al.. (2013). Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help?. Translational research. 163(1). 36–42. 23 indexed citations
10.
Lê, Phu-Quoc, Laurence Dedeken, Béatrice Gulbis, et al.. (2013). Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy. Blood. 122(21). 2231–2231. 1 indexed citations
11.
Debaugnies, France, Denis F. Noubouossie, Laurence Rozen, et al.. (2010). Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thrombosis Research. 126(6). 531–535. 22 indexed citations
12.
Roufosse, Florence, Liliane Schandené, Catherine Sibille, et al.. (2000). Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. British Journal of Haematology. 109(3). 540–548. 142 indexed citations
13.
Schandené, Liliane, Florence Roufosse, Aurore de Lavareille, et al.. (2000). Interferon α prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 96(13). 4285–4292. 1 indexed citations
14.
Camp, Guy Van, et al.. (1996). Intracardiac thrombi associated with antiphospholipid antibodies. Journal of the American Society of Echocardiography. 9(6). 891–893. 15 indexed citations
15.
Postelmans, Laurence, Claire Verougstraete, Jacques Libert, André Efira, & L Caspers-Velu. (1996). [Intravenous corticosteroid megadose treatment in ocular Behçet disease].. PubMed. 262. 95–103. 3 indexed citations
16.
Efira, André, et al.. (1990). Acute myelofibrosis. Case report and review of the literature.. PubMed. 45(4). 231–2. 1 indexed citations
17.
Cauchie, P., et al.. (1988). Tuberculosis: cause of death in Brussels.. PubMed. 139(2). 132–3. 2 indexed citations
18.
Efira, André, et al.. (1986). Platelet Survival in Myelodysplastic Syndromes. Acta Haematologica. 76(2-3). 124–126. 2 indexed citations
19.
Efira, André, et al.. (1983). A Case of L1 Acute Lymphoblastic Leukaemia Relapsing in L3 (Burkitt's Type) with Non‐T, Non‐B Cells. Scandinavian Journal of Haematology. 30(4). 384–388.
20.
Efira, André, et al.. (1980). Lithium in Haematology: A Case of Acute Intoxication. Acta Haematologica. 64(6). 335–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Segal Breakdown of academic impact, for papers by Susana Holgado Breakdown of academic impact, for papers by Ali H. Al‐Jam'a Breakdown of academic impact, for papers by Masao Ogura Breakdown of academic impact, for papers by Mathieu Jablonski Breakdown of academic impact, for papers by M Massazza Breakdown of academic impact, for papers by Shuji Takei Breakdown of academic impact, for papers by Dominique Desvaux Breakdown of academic impact, for papers by Rodolfo Puccini Breakdown of academic impact, for papers by C.F. Allaart
Rankless by CCL
2026